Join to view full profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Gangat is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2007 - 2010
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2004 - 2007
Aga Khan Medical CollegeClass of 2002
Certifications & Licensure
MN State Medical License 2006 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2014, 2016-2017
Clinical Trials
- Actuate 1901: 9-ING-41 in Myelofibrosis Start of enrollment: 2020 Aug 20
Roles: Contact
Publications & Presentations
PubMed
- Older Age, STAG2, and DNMT3A Mutations Predict Superior Posttransplant Survival in Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating ...Momna Warraich, Sudhesh Kumar, Mahnoor Fatima, Kristen McCullough, Aref Al-Kali
American Journal of Hematology. 2026-11-01 - Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.Abiola Bolarinwa, Aref Al-Kali, Hassan B Alkhateeb, Abhishek A Mangaonkar, Antoine N Saliba
American Journal of Hematology. 2026-10-01 - 1 citationsNext generation sequencing panel for hereditary erythrocytosis in adults with otherwise unexplained erythrocytosis unveils additional genomic variants.Mahsa Rezasoltani, Jennifer L Herrick, Aruna Rangan, Xi Zhang, Animesh Pardanani
Haematologica. 2026-10-01
Journal Articles
- MPL-Mutated Essential Thrombocythemia: A Morphologic ReappraisalNaseema Gangat, Natasha Szuber, Rhett P Ketterling, Nature
- Determinants of Long-Term Outcome in Type 1 Calreticulin-Mutated MyelofibrosisNaseema Gangat, Natasha Szuber, Rhett P Ketterling, Nature
Press Mentions
“How Are the 2026 AML Algorithms Reshaping Frontline Therapy?April 1st, 2026
Talha Badar: Key Hematologic Malignancy Posters from ASCO26June 2nd, 2026
Naveen Pemmaraju: A New Era for Myeloproliferative Neoplasms at SOHO 2026September 12th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
